Oncology: Plan Ahead To Rule Out Harm When Survival Not The Endpoint, US FDA Says

 
• By Michael McCaughan
  
The guidance builds on discussions of the issue at workshops and other events. (Shutterstock)

More from Clinical Trials

More from United States